Incurred Sample Reanalysis

Incurred Sample Reanalysis is a bioanalytical quality assurance process in which previously analyzed biological samples, containing analytes formed in vivo following administration of a drug to a subject, are reanalyzed to assess the reliability, reproducibility, and integrity of the original bioanalytical results.

35

Publications

775

Citations

265

Authors

105

Institutions

Publications per year

2017–2026

11

Authors

265

  1. FG
    Fabio Garofolo

    Bristol-Myers Squibb (United States), United States

    4 publications · 180 citations

    4

    h-index

  2. EW
    Enaksha Wickremsinhe

    Eli Lilly (United States), United States

    4 publications · 52 citations

    4

    h-index

  3. ML
    Mario L. Rocci

    Jefferson College, United States

    4 publications · 153 citations

    4

    h-index

  4. LC
    Laura Cojocaru

    MPI Research (United States), United States

    4 publications · 162 citations

    4

    h-index

  5. SK
    Shane Karnik

    Pharmaceutical Product Development (United States), United States

    3 publications · 141 citations

    3

    h-index

1–5 of 265

Venues

  1. Bioanalysis

    BIO · 28 publications · 648 citations

    14

    h-index

  2. The AAPS Journal

    AAPSJ · 2 publications · 28 citations

    2

    h-index

  3. Scientific Reports

    2 publications · 56 citations

    2

    h-index

  4. 1

    h-index

  5. Biomedical Chromatography

    BMC · 1 publications · 15 citations

    1

    h-index

1–5